Study drug HM97662 for advanced solid tumors that stopped working
Part of Cancer clinical trials.
This Phase 1 trial tests how to find a safe dose of HM97662 and then study it further in people with advanced or metastatic solid tumors. It may help people whose usual treatments have failed or were not tolerated by checking whether HM97662 can control tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have an advanced or metastatic solid tumor that has failed or you couldn’t tolerate standard treatment.
- You must be able to be assessed with scans: measurable tumor spots on CT or MRI (for some parts, evaluable disease is enough).
- Your overall health/activity level is ECOG 0 or 1, meaning you can do most daily activities or are limited but ambulatory.
- Your kidneys, blood counts, and liver tests must be “adequate” for study treatment.
- You must have at least 3 months of expected life remaining and be age 18 or older (or the adult age in your country).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug, HM16390, either by itself or combined with pembrolizumab, for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to find the best dose and see if it can shrink tumors.
This Phase 1/2 trial tests MHB036C in people with advanced or metastatic solid cancers that have stopped responding to standard treatments (or no standard options exist). It is meant to see how the drug works and how safe it is in this group.
This Phase 1 trial tests HS-10386 (an experimental treatment) in people with advanced solid tumors that can’t be cured with standard options. The goal is to find a safe dose and see how the cancer responds.
This Phase 1 trial tests HS-20089 in people with advanced solid cancers that have limited standard treatment options. It focuses on safety and early signs of whether the drug can shrink tumors or control them.
This trial tests a new drug called HSK39775 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug is safe and effective for people who have few other options.
This trial tests an experimental drug called MHB046C for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if it can shrink tumors or slow their growth.
Hear when a new Advanced or Metastatic Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.